DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,437,360 | -30.6% | 113,000 | -23.1% | 0.01% | -33.3% |
Q2 2023 | $2,069,760 | +59.5% | 147,000 | +75.0% | 0.01% | +28.6% |
Q1 2023 | $1,297,800 | -10.0% | 84,000 | -4.5% | 0.01% | 0.0% |
Q4 2022 | $1,442,320 | -50.7% | 88,000 | -44.3% | 0.01% | -50.0% |
Q3 2022 | $2,923,000 | +40.7% | 158,000 | 0.0% | 0.01% | +55.6% |
Q2 2022 | $2,078,000 | +647.5% | 158,000 | +426.7% | 0.01% | +800.0% |
Q1 2022 | $278,000 | -96.1% | 30,000 | -75.0% | 0.00% | -98.2% |
Q2 2020 | $7,154,000 | – | 119,800 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |